FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to experimental pharmacology and gastroenterology. 50 minutes before the introduction of the ulcerogenic agent, which is the non-steroidal anti-inflammatory drug diclofenac, N-isopropenylimidazole zincodiacetate 10 mg/kg or 20 mg/kg is administered intragastrically once.
EFFECT: method enables using N-isopropenylimidazole zincodiacetate to increase the effectiveness of preventing ulceration of the gastric mucosa, which in turn enables to expand the range of antiulcerogenic drugs and reduce their toxic effect.
1 cl, 1 dwg, 1 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| 3-[3-(MORPHOLINE-4-YL)PROPYL]-2-[(2,2,3-TRIMETHYLCYCLOPENT-3-ENE-1-YL)METHYL-1,3-THIAZOLIDINE-4-ONE WITH ANTI-ULCER AND ANTI-INFLAMMATORY ACTIVITY | 2017 |
|
RU2643669C1 |
| METHOD FOR PREVENTION OF GASTRIC MUCOSA ULCERATION | 2011 |
|
RU2481111C1 |
| MEANS WITH GASTROPROTECTIVE ACTIVITY | 2016 |
|
RU2629090C1 |
| METHOD FOR PREVENTION OF ULCERATION OF GASTRIC MUCOSA | 2020 |
|
RU2744455C1 |
| 5-ETHYL-2-AMINO-1,3,4-THIADIAZOLE DERIVATIVES WITH ANESTHETIC, ANTI-INFLAMMATORY, ANTI-ALLERGIC AND ANALGETIC ACTIVITY | 2016 |
|
RU2651572C2 |
| REMEDY FOR THE TREATMENT OF ULCERS IN ANIMALS | 2021 |
|
RU2773316C1 |
| BIOLOGICALLY ACTIVE FOOD SUPPLEMENT "BIOSINOL", WHICH POSSESSES GASTROPROTECTIVE ACTIVITY | 2009 |
|
RU2397775C1 |
| ANTI-ULCEROGENIC AGENT | 1997 |
|
RU2143909C1 |
| AGENT POSSESSING ANTI-INFLAMMATORY, ANTIOXIDANT AND ANTIULCEROGENIC ACTION, ABILITY TO INHIBIT DEVELOPMENT OF DEGENERATIVE-DESTRUCTIVE PROCESSES OF TISSUES, WHICH IS 2-ETHYL-6-METHYL-3-HYDROXYPYRIDINIUM-4-ISOBUTYLPHENYLPROPANOATE | 2023 |
|
RU2814495C1 |
| ANTIULCER AGENT | 2001 |
|
RU2184559C1 |
